
- /
- Supported exchanges
- / US
- / CDIO.NASDAQ
Cardio Diagnostics Holdings Inc (CDIO NASDAQ) stock market data APIs
Cardio Diagnostics Holdings Inc Financial Data Overview
Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. The company offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment clinical blood test targeting CHD events, including heart attacks; PrecisionCHD, an integrated epigenetic-genetic clinical blood test for the detection of coronary heart disease; and Actionable Clinical Intelligence, a platform that offers new epigenetic and genetic insights to clinicians prescribing to help improve chronic care management. It also provides CardioInnovate360, a research-use-only solution to support the discovery, development and validation of novel biopharmaceuticals for the assessment and management of cardiovascular diseases; and HeartRisk, a SaaS cardiovascular disease risk intelligence platform. It serves telemedicine providers; provider organizations, including concierge practices, longevity clinics, and risk-bearing provider organizations; and employer organizations. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is headquartered in Chicago, Illinois.
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get Cardio Diagnostics Holdings Inc data using free add-ons & libraries
Get Cardio Diagnostics Holdings Inc Fundamental Data
Cardio Diagnostics Holdings Inc Fundamental data includes:
- Net Revenue: 19 507
- EBITDA: -5 853 276
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-08-14
- EPS/Forecast: -0.22
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Cardio Diagnostics Holdings Inc News

e.l.f. Beauty’s CDIO says she’s responsible for AI’s foundation, but that these tools aren’t an IT mandate
Ekta Chopra, the chief digital information officer of e.l.f. Beauty, says the fast-growing beauty brand is piloting 85 different agentic artificial intelligence use cases. But giving employees more ac...


Medicare sets preliminary payment rates for Cardio Diagnostics tests
CHICAGO - The Centers for Medicare and Medicaid Services (CMS) has issued preliminary gapfill payment rates for two cardiovascular tests developed by Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIO), a...

Cardio Diagnostics regains Nasdaq compliance following reverse stock split
* Cardio Diagnostics Holdings (NASDAQ:CDIO [https://seekingalpha.com/symbol/CDIO]) received a Nasdaq notice confirming compliance with the $1 minimum bid price requirement. * The compliance follow...

11 Hot Healthcare Stocks To Buy Now
In this article, we will be taking a look at 11 hot healthcare stocks to buy now. To skip our detailed analysis of the healthcare sector, you can go directly to see the 5 Hot Healthcare Stocks To Buy ...
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.